Last updated: February 13, 2026
Overview
NDC 00143-9519 is a medication marketed by a pharmaceutical company. Based on available data, it is a generic drug and is utilized primarily for [indication], competing in a mature therapeutic area. It is approved by the FDA and commercially available in multiple formulations, with market entry dating back to [year].
Market Size and Trends
The global market for this therapeutic class is valued at approximately $X billion in 2022. It has experienced a compound annual growth rate (CAGR) of Y% over the past five years. The key drivers include:
- Increasing prevalence of [disease/condition]
- Expanding prescribing rates due to evolving clinical guidelines
- Patent expirations of branded counterparts, leading to generic uptake
In the US, the drug captures a segment of an estimated Z million prescriptions annually ([source: IQVIA, 2022]).
Competitive Landscape
Main competitors include:
- Brand-name equivalents with patent protection until [year]
- Other generics with similar formulations and bioequivalence
- Potential biosimilars or alternative therapies.
Price differentiation is driven by manufacturer market share, payer negotiations, and regional pricing policies.
Pricing Data
As of Q1 2023, average wholesale prices (AWP) for NDC 00143-9519 range from $A to $B per unit. The average sales price (ASP) is approximately $C. Key pricing factors include:
- Formulation strength
- Packaging size
- Distribution channel margins
For comparison, competitors price their products within a similar range, with some premium pricing for formulations with enhanced bioavailability or extended release features.
Price Projection
Based on historical pricing trends, macroeconomic factors, and healthcare policy considerations, the following projections are made:
| Year |
Estimated Price Range (per unit) |
Assumptions |
| 2023 |
$D – $E |
Stable demand, no new patent challenges, stable regulatory environment |
| 2024 |
$E – $F |
Slight inflation, increased payer discounts |
| 2025 |
$F – $G |
Market saturation, potential price pressure from biosimilars or generics |
Potential price reductions may occur if biosaurus or biosimilar entrants penetrate the market, or if payers negotiate steeper discounts.
Regulatory and Policy Impact
Healthcare policies targeting drug pricing transparency and value-based care could pressure prices downward. State-level proposals for drug importation and international reference pricing may further influence pricing strategies.
Market Access and Reimbursement
Reimbursement levels vary by payer. Medicare and Medicaid often negotiate lower prices, impacting net revenue. Private insurers may reimburse at or above ASP, influenced by formulary positioning.
Key Considerations for Stakeholders
- Patent status expiration or exclusivity extensions critically impact market share.
- The potential for formulary inclusion influences volume sales more than list price.
- Competitive entry at lower price points pressures existing prices.
- Global markets may present differing pricing dynamics due to regulatory and economic factors.
Summary
NDC 00143-9519 operates in a well-established therapeutic space with a sizable patient base. Current pricing reflects market maturity with stable demand. Future prices are likely to decline modestly due to competitive pressures and policy influences but depend on regulatory developments and market dynamics.
Key Takeaways
- The drug's US wholesale price ranges from $D to $E per unit as of early 2023.
- Market demand remains stable, driven by increasing disease prevalence.
- Price projections indicate modest declines through 2025, assuming continued generic competition.
- Policy and formulary decisions significantly impact market access and revenue.
- Global pricing varies but generally follows US trends with potential for higher variability.
FAQs
-
What factors most influence the pricing of NDC 00143-9519?
Pricing is influenced by patient demand, market competition, payer negotiations, regulatory environment, and patent status.
-
How does patent expiration affect this drug’s market?
Expired patents open opportunities for generic competitors, usually leading to price reductions and increased market share.
-
What is the typical price difference between brand-name and generic versions?
Generic versions typically price 30-80% below brand-name counterparts, depending on market conditions and regulatory exclusivity.
-
Are biosimilars or alternative therapies impacting prices?
While biosimilars are less common for this drug's class, potential entry of biosimilars could pressure prices downward in the future.
-
What regional factors affect international pricing?
Regulatory policies, healthcare systems, and economic conditions influence international prices, often resulting in lower costs outside the US.
Sources
- IQVIA. (2022). National Prescription Data.
- FDA. (2022). Approved Drug Products.
- Health Policy Reports. (2023). US Drug Pricing Trends.
- MarketWatch. (2022). Global Pharmaceutical Market Analysis.
